SymBio Pharmaceuticals Limited (4582.T)

JPY 212.0

(-1.85%)

Annual Balance Sheets

(In JPY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 15.35 Billion 10.43 Billion 8.45 Billion 6.27 Billion 5.27 Billion 6.23 Billion
Total Current Assets 8.08 Billion 9.31 Billion 6.74 Billion 5.81 Billion 4.88 Billion 6.03 Billion
Cash And Short Term Investments 6.51 Billion 6.28 Billion 3.86 Billion 3.84 Billion 3.91 Billion 4.82 Billion
Cash and Cash Equivalents 6.51 Billion 6.28 Billion 3.86 Billion 3.84 Billion 3.91 Billion 4.82 Billion
Short Term Investments - - - - - -
Net Receivables 913.09 Million 2.54 Billion 2.48 Billion 845.88 Million 960.39 Million 651.09 Million
Inventory 232.03 Million 469.37 Million 385.68 Million 944.92 Million 640 Thousand 534.41 Million
Other Current Assets 420.39 Million 13.22 Million 16.95 Million 175.85 Million 15.62 Million 31.62 Million
Total Non-Current Assets 7.26 Billion 1.12 Billion 1.7 Billion 459.41 Million 386.46 Million 200.93 Million
Net PPE 87.71 Million 153.7 Million 170.29 Million 157.57 Million 145.93 Million 128.32 Million
Good Will And Intangible Assets -87 Million 222.2 Million 259.1 Million 301.84 Million 240.52 Million 71.37 Million
Good Will - - - - - -
Intangible Assets - 222.2 Million 259.1 Million 301.84 Million 240.52 Million 71.37 Million
Long-Term Investments 87 Million 85 Million -86.66 Million - - -
Tax Assets 7.18 Billion 744.72 Million 1.27 Billion - - -
Other Non Current Assets 1000.00 -85 Million 86.66 Million - - 1.22 Million
Other Assets - - 1000.00 1000.00 2000.00 3000.00
Total Liabilities 8.14 Billion 1.92 Billion 1.7 Billion 1.61 Billion 873.83 Million 1.33 Billion
Total Current Liabilities 956.62 Million 1.92 Billion 1.51 Billion 1.61 Billion 872.21 Million 1.33 Billion
Account Payables - 46.63 Million 69.68 Million 665.46 Million 120.91 Million 726.1 Million
Tax Payables 18.47 Million 401.06 Million 899.63 Million 81.92 Million 87.75 Million 71.24 Million
Short Term Debt - - - -192.7 Million - -
Deferred Revenue - - - 192.7 Million - -
Other Current Liabilities 956.62 Million 1.87 Billion 1.44 Billion 949.87 Million 751.3 Million 610.24 Million
Total Non Current Liabilities 7.18 Billion 3.38 Million 189.21 Million 2.05 Million 1.62 Million 1.28 Million
Long-Term Debt - - - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.7 Million -6.99 Billion -6.53 Billion 2.05 Million 1.62 Million 1.28 Million
Other Liabilities - - - - - -
Total Equity 7.2 Billion 8.5 Billion 6.74 Billion 4.65 Billion 4.4 Billion 4.9 Billion
Stock Holders Equity 7.2 Billion 8.5 Billion 6.74 Billion 4.65 Billion 4.4 Billion 4.9 Billion
Common Stock 17.95 Billion 17.54 Billion 17.15 Billion 17.04 Billion 14.87 Billion 12.97 Billion
Retained Earnings -28.85 Billion -26.88 Billion -27.97 Billion -30 Billion -25.91 Billion -21.54 Billion
Accumulated other comprehensive income 271.05 Million 411.91 Million 519.09 Million 620.14 Million 620.91 Million 529.89 Million
Common Stock Equity 7.2 Billion 8.5 Billion 6.74 Billion 4.65 Billion 4.4 Billion 4.9 Billion
Capital Lease Obligation - - - - - -
Total Investments 87 Million 85 Million -86.66 Million - - -
Total Debt - - - - - -
Net Debt -6.51 Billion -6.28 Billion -3.86 Billion -3.84 Billion -3.91 Billion -4.82 Billion

Balance Sheet Charts